Riskpilot← Back to searchSign inGet full accessLEGER I NORD AS
ASActiveOrg 999209424City Nord Stormyra, 8008 BodøGeneral medical practice activities · NACE 8621Est. 20125 employees
Revenue 2025
NOK 5,6M
+4% vs 2024
EBITDA margin
0.0%
-100% vs 2024
Equity ratio
24.5%
Financial strength
Net profit 2025
NOK -1
-100% vs 2024
| Revenue | NOK 5,6M | +4% |
| EBITDA | NOK 63 | -100% |
| Net profit | NOK -1 | -100% |
| Total assets | NOK 609K | -8% |
| Equity | NOK 149K | +0% |
| Employees | 5 | — |
Legal name
LEGER I NORD AS
Org number
999209424
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. desember 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Levere administrasjonstjenester til samarbeidende leger.
Address
City Nord Stormyra, 8008 Bodø
Phone
+4775550600
Email
murtaza.sh@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 606 | 4 813 | 5 254 | 5 402 | 5 609 |
| Staff expenses | −2 129 | −2 214 | −2 355 | −2 491 | −2 661 |
| EBITDA | 61 | −6 | 180 | 141 | 0 |
| Depreciation & amort. | −73 | −51 | −40 | −0 | −0 |
| EBIT | −12 | −57 | 140 | 141 | 0 |
| Net financials | 0 | −0 | −0 | −0 | −0 |
| Profit before tax | −12 | −57 | 140 | 141 | −0 |
| Tax | −0 | −0 | 23 | 27 | −0 |
| Net profit | −12 | −57 | 117 | 115 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 690 | 388 | 931 | 664 | 609 |
| Equity | −26 | −83 | 34 | 149 | 149 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 716 | 470 | 897 | 515 | 460 |
| Total debt | 716 | 470 | 897 | 515 | 460 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20212025
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
9.22×
This company
1.12×
Market median
+723% vs market
20212025
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EL Chief Executive Officer | Chief Executive Officer | 2012 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LEGER I NORD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ellen Langen | Chief Executive Officer | 0 companies |